Thymia

Introducing Thymia: making mental health as objectively measurable as physical health.

Mental health is a huge societal and economic problem, with 1 billion people affected and suboptimal diagnostic tools resulting in decades-long delays in treatment.

Thymia makes mental health objectively measurable with clinical accuracy, similar to how physical health is tracked, helping to detect, track, predict, and prevent mental health issues.

Our world-leading team includes experts in cognitive biomarkers, multi-modal models, finance, operations, and emotion-detection AI, making us the perfect team to tackle this global issue.

We offer AI models that uniquely combine multiple inputs to assess a range of symptoms and conditions and package these as flexible, scalable APIs and widgets that fit any platform.

Our long-term strategy involves dominating the clinical space within five years, with a focus on primary and secondary care, along with digital healthcare, as key target markets.

We aim to reach Series A metrics by Q3 2024 by hitting revenue targets, expanding user engagement, adding new product features, and securing medical device regulation and IP patents.